Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLiver TransplantationLeukemiaTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicCyclophosphamideKidney TransplantationBone Marrow DiseasesHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationGraft RejectionImmunosuppressive AgentsTreatment OutcomeHematologic NeoplasmsRemission InductionTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsLeukemia, MyeloidImmunosuppressionLeukocyte TransfusionLymphocyte DepletionHeart TransplantationStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinT-LymphocytesSevere Combined ImmunodeficiencyHLA AntigensChimeraColony-Forming Units AssaySurvival AnalysisRetrospective StudiesMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesBlood DonorsBone DensityLymphocyte TransfusionOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaFollow-Up StudiesSurvival RateCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorMice, Inbred BALB CBone ResorptionMelphalanDisease-Free SurvivalFlow CytometryEtoposideLymphomaMultiple MyelomaCells, CulturedFatal OutcomeAntigens, CD34Mice, KnockoutCell TransplantationHodgkin DiseaseCord Blood Stem Cell TransplantationInfection